<Record>
<Term>Immunoblastic Lymphadenopathy</Term>
<SemanticType>Disease or Syndrome</SemanticType>
<ParentTerm>Lymphoproliferative Disorders</ParentTerm>
<ClassificationPath>Hemic and Lymphatic Diseases/Lymphatic Diseases/Lymphoproliferative Disorders/Immunoblastic Lymphadenopathy</ClassificationPath>
<ClassificationPath>Immune System Diseases/Immunoproliferative Disorders/Lymphoproliferative Disorders/Immunoblastic Lymphadenopathy</ClassificationPath>
<BroaderTerm>Hemic and Lymphatic Diseases</BroaderTerm>
<BroaderTerm>Immunoblastic Lymphadenopathy</BroaderTerm>
<BroaderTerm>Immune System Diseases</BroaderTerm>
<BroaderTerm>Lymphatic Diseases</BroaderTerm>
<BroaderTerm>Immunoproliferative Disorders</BroaderTerm>
<BroaderTerm>Lymphoproliferative Disorders</BroaderTerm>
<Synonym>Immunoblastic Lymphadenopathy</Synonym>
<Synonym>Angioimmunoblastic Lymphadenopathies</Synonym>
<Synonym>Angioimmunoblastic Lymphadenopathy</Synonym>
<Synonym>Immunoblastic Lymphadenopathies</Synonym>
<Description>A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly.</Description>
<Source>MeSH</Source>
</Record>
